Yaneicy Gonzalez‐Rojas

Effect of Sotrovimab on Hospitalization or Death Among High-risk Patients With Mild to Moderate COVID-19

Anil Kumar Gupta, Yaneicy Gonzalez‐Rojas, Erick Stanley Petersen Juárez et al. · JAMA · 2022 · 294 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacotherapy +12

Efficacy of Inhaled Ciclesonide for Outpatient Treatment of Adolescents and Adults With Symptomatic COVID-19

Brian M. Clemency, Renoj Varughese, Yaneicy Gonzalez‐Rojas et al. · JAMA Internal Medicine · 2021 · 106 citations · Full text

Pharmacy, Clinical Sciences, Pharmacotherapy +17

Ceftobiprole Compared With Vancomycin Plus Aztreonam in the Treatment of Acute Bacterial Skin and Skin Structure Infections: Results of a Phase 3, Randomized, Double-blind Trial (TARGET)

J. Scott Overcash, Charles Kim, Richard Keech et al. · Clinical Infectious Diseases · 2020 · 64 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Early Covid-19 Treatment With SARS-CoV-2 Neutralizing Antibody Sotrovimab

Anil Kumar Gupta, Yaneicy Gonzalez‐Rojas, Erick Stanley Petersen Juárez et al. · medRxiv · 2021 · 53 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Intramuscular vs Intravenous SARS-CoV-2 Neutralizing Antibody Sotrovimab for Treatment of COVID-19 (COMET-TAIL): A Randomized Noninferiority Clinical Trial

Adrienne E. Shapiro, Elias Sarkis, Jude Acloque et al. · Open Forum Infectious Diseases · 2023 · 21 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +12